News
SAN ANTONIO, June 26, 2025--bioAffinity scientists present breakthrough research on using siRNAs to knock down two receptors ...
Approved eight months ago for a certain class of patients with both hemophilia A or B, Pfizer’s Hympavzi has now shown its ...
23h
News-Medical.Net on MSNRibonucleases revealed as key players in Mendelian disordersA new review brings to light the pivotal role of ribonucleases (RNases) in shaping the molecular foundation of Mendelian ...
New AI helps unlock how tiny RNAs (piRNAs) control genes by binding to genetic instructions (mRNAs). This breakthrough in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results